# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001000694-24-000007
Filing Date
2024-02-28
Accepted
2024-02-28 07:30:55
Documents
128
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | nvax-20231231.htm iXBRL | 10-K | 2423507
2 | EX-4.4 | nvax-20231231xex44.htm | EX-4.4 | 22487
3 | EX-10.28 | nvax-20231231xex1028.htm | EX-10.28 | 48395
4 | EX-10.32 | nvax-20231231xex1032.htm | EX-10.32 | 18659
5 | EX-10.33 | nvax-20231231xex1033.htm | EX-10.33 | 85139
6 | EX-10.34 | nvax-20231231xex1034.htm | EX-10.34 | 17063
7 | EX-10.35 | nvax-20231231xex1035.htm | EX-10.35 | 66254
8 | EX-10.36 | nvax-20231231xex1036.htm | EX-10.36 | 16991
9 | EX-10.37 | nvax-20231231xex1037.htm | EX-10.37 | 55256
10 | EX-10.101 | nvax-20231231xex10101.htm | EX-10.101 | 348018
11 | EX-21 | nvax-20231231xex21.htm | EX-21 | 4678
12 | EX-23.1 | nvax-20231231xex231.htm | EX-23.1 | 15407
13 | EX-31.1 | nvax-20231231xex311.htm | EX-31.1 | 11345
14 | EX-31.2 | nvax-20231231xex312.htm | EX-31.2 | 11730
15 | EX-32.1 | nvax-20231231xex321.htm | EX-32.1 | 5877
16 | EX-32.2 | nvax-20231231xex322.htm | EX-32.2 | 6191
17 | EX-97 | nvax-20231231xex97.htm | EX-97 | 27536
23 |  | image.jpg | GRAPHIC | 8518
24 |  | image1a.jpg | GRAPHIC | 8616
25 |  | image_01a.jpg | GRAPHIC | 185
26 |  | image_02a.jpg | GRAPHIC | 24569
27 |  | image_0a.jpg | GRAPHIC | 282
28 |  | image_0b.jpg | GRAPHIC | 4135
29 |  | image_1a.jpg | GRAPHIC | 187
30 |  | image_2a.jpg | GRAPHIC | 186
31 |  | nvax-20231231_g1.jpg | GRAPHIC | 268376
32 |  | nvax-20231231_g2.jpg | GRAPHIC | 94172
| Complete submission text file | 0001000694-24-000007.txt |  | 13490203

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
18 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | nvax-20231231.xsd | EX-101.SCH | 78979
19 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | nvax-20231231_cal.xml | EX-101.CAL | 104659
20 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | nvax-20231231_def.xml | EX-101.DEF | 441161
21 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | nvax-20231231_lab.xml | EX-101.LAB | 1042369
22 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | nvax-20231231_pre.xml | EX-101.PRE | 703299
130 | EXTRACTED XBRL INSTANCE DOCUMENT | nvax-20231231_htm.xml | XML | 1636862

Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26770 | Film No.: 24690178
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)